January 2024 TRANSCRIPTION FACTORS INFLUENCE INSULIN-PRODUCING BETA CELLSFeaturing: Joseph Bass, MD, PhD and Benjamin Weidemann
A new study by researchers at Northwestern University Feinberg School of Medicine has identified a group of transcription factors that play a crucial role in the development of insulin-producing beta cells. The study, which was published in the journal Cell Metabolism, found that these transcription factors are responsible for regulating the expression of genes that are essential for the proper functioning of beta cells. The researchers used a combination of genetic and biochemical techniques to identify the transcription factors that are involved in the development of beta cells. They found that these factors work together to control the expression of genes that are involved in the production and secretion of insulin. The study also revealed that the transcription factors are involved in the regulation of other cellular processes that are important for the proper functioning of beta cells. The findings of this study have important implications for the development of new treatments for diabetes. By understanding the role of transcription factors in the development of beta cells, researchers may be able to develop new therapies that target these factors and improve the function of beta cells in people with diabetes. *This article was originally published in the Northwestern University Feinberg School of Medicine News Center on January 30, 2024. |
Joseph Bass, MD, PhD, the Charles F. Kettering Professor of Medicine and chief of Endocrinology in the Department of Medicine, was senior author of the study published in Cell Metabolism.
Benjamin Weidemann, a student in the Medical Scientist Training Program, was the lead author of the study.
Refer a PatientNorthwestern Medicine welcomes the opportunity to partner with you in caring for your patients.
|